Status:
UNKNOWN
VR for Improving Attention and Working Memory
Lead Sponsor:
Medical University of Lodz
Collaborating Sponsors:
National Center for Research and Development, Poland
Senopi AG
Conditions:
Virtual Reality
Eligibility:
All Genders
65-85 years
Phase:
NA
Brief Summary
The main objective of the study is to investigate the effects of using a set of Virtual Reality (VR)-based Digital Therapeutics (DTx) apps to improve the cognitive abilities of healthy (high-functioni...
Detailed Description
The participants that meet inclusion criteria will be randomly assigned to the experimental group or the control group. The participants in the experimental group will receive a cognitive intervention...
Eligibility Criteria
Inclusion
- Healthy or in a stable medical condition
- Undisturbed locomotion
- Do not require care or help from others in their everyday functioning
- Are able to go on long walks unassisted
- Are able to use common modern technology unassisted (e.g. using a smartphone to send a message)
Exclusion
- Presence of neuropsychiatric disorders, including mild cognitive impairment (MCI) - Montreal Cognitive Assessment (MoCA) score \<26 points
- Abuse or addiction to alcohol, drugs and tranquilizers
- Blurred vision that cannot be corrected with lenses or glasses that fit under the VR headset
- Auditory pathologies causing a significant decrease in hearing unaided
- High sensitivity to motion sickness
- Proneness to migraines
- Subject epileptic
- Subject vulnerable
- Subject obese or frail, as assessed based on their Body Mass Index (BMI)
- Subject considered by the study investigator to be an unsuitable candidate to participate in the study, due to other relevant reasons
Key Trial Info
Start Date :
April 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05369897
Start Date
April 30 2022
End Date
June 1 2023
Last Update
July 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Old Age Psychiatry and Psychotic Disorders Medical University of Lodz
Lodz, Poland, 92-213